Amin Alousi

Amin Alousi

UNVERIFIED PROFILE

Are you Amin Alousi?   Register this Author

Register author
Amin Alousi

Amin Alousi

Publications by authors named "Amin Alousi"

Are you Amin Alousi?   Register this Author

100Publications

4883Reads

34Profile Views

Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2019 Sep 10. Epub 2019 Sep 10.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.09.006DOI Listing
September 2019

The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) Index.

Biol Blood Marrow Transplant 2019 Aug 5. Epub 2019 Aug 5.

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.07.040DOI Listing
August 2019

HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.

Curr Res Transl Med 2019 May 23;67(2):51-55. Epub 2019 Jan 23.

The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.retram.2019.01.001DOI Listing
May 2019

Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia.

Biol Blood Marrow Transplant 2018 07 12;24(7):1514-1520. Epub 2018 Feb 12.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.02.003DOI Listing
July 2018

New and emerging therapies for acute and chronic graft host disease.

Ther Adv Hematol 2018 Jan 28;9(1):21-46. Epub 2017 Nov 28.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 0423, Houston, TX 77030-4000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620717741860DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753923PMC
January 2018

Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes.

Biol Blood Marrow Transplant 2017 Dec 24;23(12):2166-2171. Epub 2017 Aug 24.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.08.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889108PMC
December 2017

Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease.

Am J Surg Pathol 2017 Nov;41(11):1483-1490

Departments of *Stem Cell Transplantation and Cellular Therapy †Pathology ‡Gastroenterology, The University of Texas M.D. Anderson Cancer Center §Department of Pediatric Oncology, Baylor College of Medicine, Houston, TX ∥Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000914DOI Listing
November 2017

Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation.

Biol Blood Marrow Transplant 2017 Aug 8;23(8):1405-1410. Epub 2017 May 8.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.04.027DOI Listing
August 2017

Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery.

Biol Blood Marrow Transplant 2017 Aug 12;23(8):1359-1366. Epub 2017 May 12.

Department of Stem Cell Transplantation and Cellular Therapy, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453532PMC
August 2017

Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma.

Biol Blood Marrow Transplant 2017 Jul 4;23(7):1059-1063. Epub 2017 Apr 4.

The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.03.030DOI Listing
July 2017

Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.

J Clin Oncol 2017 May 15;35(15):1650-1659. Epub 2017 Mar 15.

Jonathan U. Peled, Sean M. Devlin, Anna Staffas, Melissa Lumish, Raya Khanin, Eric R. Littmann, Lilan Ling, Satyajit Kosuri, Molly Maloy, John B. Slingerland, Katya F. Ahr, Kori A. Porosnicu Rodriguez, Yusuke Shono, Ann E. Slingerland, Melissa D. Docampo, Boglarka Gyurkocza, Doris M. Ponce, Juliet N. Barker, Miguel-Angel Perales, Sergio A. Giralt, Ying Taur, Eric G. Pamer, Robert R. Jenq, and Marcel R.M. van den Brink, Memorial Sloan Kettering Cancer Center; Jonathan U. Peled, Melissa D. Docampo, Boglarka Gyurkocza, Doris M. Ponce, Juliet N. Barker, Miguel-Angel Perales, Sergio A. Giralt, Ying Taur, Eric G. Pamer, Robert R. Jenq, and Marcel R.M. van den Brink, Weill Cornell Medical College; Melissa Lumish, New York University Langone Medical Center, New York, NY; Anthony D. Sung, Duke University Medical Center, Durham, NC; Daniela Weber, University Medical Center, Regensburg, Germany; and Amin M. Alousi, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.3348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455763PMC
May 2017

Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia.

Biol Blood Marrow Transplant 2016 Jan 4;22(1):47-53. Epub 2015 Sep 4.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas; Transplant Myeloid Study Group, Department of Stem Cell Transplant and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.08.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892364PMC
January 2016

A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality.

Biol Blood Marrow Transplant 2015 Apr 10;21(4):761-7. Epub 2015 Jan 10.

Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota; Blood and Marrow Transplant Clinical Trials Network GVHD Study Committee, Milwaukee, Wisconsin; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.01.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359643PMC
April 2015

A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.

Lancet Haematol 2015 Jan 23;2(1):e21-9. Epub 2014 Dec 23.

Blood & Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA; The Tisch Cancer Institute, The Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lanhae/PIIS2352-3026(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S235230261400035
Publisher Site
http://dx.doi.org/10.1016/S2352-3026(14)00035-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340092PMC
January 2015

Lenalidomide-induced graft-vs.-Leukemia effect in a patient with chronic lymphocytic leukemia who relapsed after allogeneic stem cell transplant.

Clin Lymphoma Myeloma Leuk 2014 Jun 27;14(3):e105-9. Epub 2013 Dec 27.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.12.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840930PMC
June 2014

Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion.

Ther Adv Hematol 2013 Oct;4(5):320-34

Department of Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620713490316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766348PMC
October 2013

Peripheral and thymic foxp3(+) regulatory T cells in search of origin, distinction, and function.

Front Immunol 2013 27;4:253. Epub 2013 Aug 27.

Department of Paediatrics, University Children's Medical Institute, National University Hospital , Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2013.00253DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753660PMC
August 2013

Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant 2013 Jul 30;19(7):1059-64. Epub 2013 Apr 30.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.04.014DOI Listing
July 2013

High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphoma.

Biol Blood Marrow Transplant 2013 Jun 16;19(6):991-4. Epub 2013 Mar 16.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.03.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411554PMC
June 2013

Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302.

Biol Blood Marrow Transplant 2013 Mar 12;19(3):481-5. Epub 2012 Dec 12.

Hematologic Malignancies, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.12.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653300PMC
March 2013

Graft-versus-host disease: state of the science.

Biol Blood Marrow Transplant 2013 Jan 27;19(1 Suppl):S102-8. Epub 2012 Oct 27.

Dept of Stem Cell Transplant and Cellular Therapy, Univeristy of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 423, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.10.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116672PMC
January 2013